Table 1.
Group | Category | SLN | CLDN | Residual disease | Locoregional disease | Distant metastases | Death of disease |
---|---|---|---|---|---|---|---|
1 | 1a | NA | NA | − | − | − | − |
1b | − | NA | − | − | − | − | |
1c | + | − | − | − | − | − | |
2 | + | + | +/− | + | − | − | |
3 | +/− | +/− | +/− | +/− | + | − | |
4 | +/− | +/− | +/− | +/− | + | + |
Definitions of clinical groupings:
Group 1:
− a – Cases with no evidence of disease after re-excision but without SLN performed
− b – Cases with no evidence of disease after re-excision and negative SLN
− c – Cases with no evidence of disease after re-excision and positive SLN
Group 2: Patients with locoregional disease in other nodes but without distant metastases
Group 3: Patients with distant metastases
Group 4: Patients with distant metastases and death due to disease